These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 29884554)
1. The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study. Rosenthal YS; Chodick G; Grossman Z; Shalev V; Koren G J Pediatr Surg; 2019 Apr; 54(4):701-706. PubMed ID: 29884554 [TBL] [Abstract][Full Text] [Related]
2. Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis. Svenningsson A; Svensson T; Akre O; Nordenskjöld A J Pediatr Surg; 2014 Aug; 49(8):1226-31. PubMed ID: 25092081 [TBL] [Abstract][Full Text] [Related]
3. Does Maternal Omega 3 Supplementation Protect Against Infantile Hypertrophic Pyloric Stenosis? Paran M; Freud E; Samuk I; Steiner Z J Pediatr Gastroenterol Nutr; 2020 May; 70(5):652-656. PubMed ID: 31990865 [TBL] [Abstract][Full Text] [Related]
4. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Abdellatif M; Ghozy S; Kamel MG; Elawady SS; Ghorab MME; Attia AW; Le Huyen TT; Duy DTV; Hirayama K; Huy NT Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884 [TBL] [Abstract][Full Text] [Related]
5. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Almaramhy HH; Al-Zalabani AH Ital J Pediatr; 2019 Feb; 45(1):20. PubMed ID: 30717812 [TBL] [Abstract][Full Text] [Related]
6. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. Lund M; Pasternak B; Davidsen RB; Feenstra B; Krogh C; Diaz LJ; Wohlfahrt J; Melbye M BMJ; 2014 Mar; 348():g1908. PubMed ID: 24618148 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010. Kapoor R; Kancherla V; Cao Y; Oleson J; Suhl J; Canfield MA; Druschel CM; Kirby RS; Meyer RE; Romitti PA Birth Defects Res; 2019 Feb; 111(3):159-169. PubMed ID: 30549250 [TBL] [Abstract][Full Text] [Related]
8. Association of prematurity with the development of infantile hypertrophic pyloric stenosis. Stark CM; Rogers PL; Eberly MD; Nylund CM Pediatr Res; 2015 Aug; 78(2):218-22. PubMed ID: 25950452 [TBL] [Abstract][Full Text] [Related]
9. Environmental exposure in the etiology of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Boybeyi-Turer O; Celik HT; Arslan UE; Soyer T; Tanyel FC; Kiran S Pediatr Surg Int; 2022 Jul; 38(7):951-961. PubMed ID: 35441884 [TBL] [Abstract][Full Text] [Related]
10. Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study. Vermes G; László D; Czeizel AE; Ács N Congenit Anom (Kyoto); 2016 Mar; 56(2):65-72. PubMed ID: 26394719 [TBL] [Abstract][Full Text] [Related]
11. Infantile hypertrophic pyloric stenosis: maternal diabetes and perinatal exposure to non-macrolide antibiotics. Cohen Elias S; Yarza S; Yerushalmi B; Shany E; Marks KA J Perinatol; 2023 Apr; 43(4):465-469. PubMed ID: 36702873 [TBL] [Abstract][Full Text] [Related]
12. Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis. Zhu J; Zhu T; Lin Z; Qu Y; Mu D J Pediatr Surg; 2017 Sep; 52(9):1389-1397. PubMed ID: 28318599 [TBL] [Abstract][Full Text] [Related]
13. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Hauben M; Amsden GW Drug Saf; 2002; 25(13):929-42. PubMed ID: 12381214 [TBL] [Abstract][Full Text] [Related]
14. The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland. Sommerfield T; Chalmers J; Youngson G; Heeley C; Fleming M; Thomson G Arch Dis Child; 2008 Dec; 93(12):1007-11. PubMed ID: 18285388 [TBL] [Abstract][Full Text] [Related]
15. Pyloric Stenosis: National Trends in the Incidence Rate and Resource Use in the United States From 2012 to 2016. Donda K; Asare-Afriyie B; Ayensu M; Sharma M; Amponsah JK; Bhatt P; Hesse MA; Dapaah-Siakwan F Hosp Pediatr; 2019 Dec; 9(12):923-932. PubMed ID: 31748239 [TBL] [Abstract][Full Text] [Related]
16. Infantile hypertrophic pyloric stenosis: a comparative study of incidence and other epidemiological characteristics in seven European regions. Pedersen RN; Garne E; Loane M; Korsholm L; Husby S; J Matern Fetal Neonatal Med; 2008 Sep; 21(9):599-604. PubMed ID: 18828050 [TBL] [Abstract][Full Text] [Related]
17. Decline in infantile hypertrophic pyloric stenosis in Germany in 2000-2008. de Laffolie J; Turial S; Heckmann M; Zimmer KP; Schier F Pediatrics; 2012 Apr; 129(4):e901-6. PubMed ID: 22430445 [TBL] [Abstract][Full Text] [Related]
18. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Cooper WO; Ray WA; Griffin MR Obstet Gynecol; 2002 Jul; 100(1):101-6. PubMed ID: 12100810 [TBL] [Abstract][Full Text] [Related]
19. Birth outcomes of male and female patients with infantile hypertrophic pyloric stenosis--a population-based case-control study. Vermes G; Mátrai Á; Czeizel AE; Ács N J Matern Fetal Neonatal Med; 2016; 29(11):1777-82. PubMed ID: 26135791 [TBL] [Abstract][Full Text] [Related]
20. [Conservative treatment of hypertrophic pyloric stenosis in children]. Sretenović A; Smoljanić Z; Korać G; Sindjeć S; Lukac M; Krstić Z Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():93-6. PubMed ID: 15615476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]